There he is. Nice! “In specific aim 1, we wil
Post# of 157707
(Total Views: 564)
Posted On: 06/22/2025 7:38:03 AM
There he is. Nice!
“In specific aim 1, we will generate and characterize AAV bearing capsids that target T and B cells specifically across both macaques and humans.
https://reporter.nih.gov/project-details/1109...ription“
“In specific aim 1, we will generate and characterize AAV bearing capsids that target T and B cells specifically across both macaques and humans.
https://reporter.nih.gov/project-details/1109...ription“
(5)
(0)CytoDyn Inc (CYDY) Stock Research Links
Daniel Rizzo
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
— Jeremiah 51:36
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
— Jeremiah 51:36